Early mortality during rifampicin-resistant TB treatment

BACK GROUND: Data suggest that treatment with newer TB drugs (linezolid [LZD], bedaquiline [BDQ] and delamanid [DLM]), used in Khayelitsha, South Africa, since 2012, reduces mortality due to rifampicin-resistant TB (RR-TB). METHODS: This was a retrospective cohort study to assess 6-month mortality a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr-Holland, E., Daniels, J., Reuter, A., Rodriguez, C. A., Mitnick, C., Kock, Y., Cox, V., Furin, J., Cox, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Union 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802559/
https://www.ncbi.nlm.nih.gov/pubmed/35086627
http://dx.doi.org/10.5588/ijtld.21.0494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802559/
https://www.ncbi.nlm.nih.gov/pubmed/35086627
http://dx.doi.org/10.5588/ijtld.21.0494

Ejemplares similares